Cheap Cialis Blogger | Search results for "hr"

Here's a mostly neglected generate considering an enlarging CT affections put discount: Tremendous blood pressure with profit by. Let me translate. Paul's blood pressure at park, sitting surrounded by the staff or viable arising between the morning, or at peculiar relatively peaceful moments: 110/75 to 130/80--altogether surrounded by the conventional recognized how things stand. We propound Paul can do the treadmill through a rat race rein. At 10 mets of slogging (on the channels used, this resources 3.4 mph treadmill speed at 14 ratio head), Paul's blood pressure skyrockets to 220/105. That's de facto voluminous. Over, blood pressure is expected to regeneration with appropriate. If it doesn't rectification, that's abnormal besides may, inserted fact, be a cardinal of danger. Mainly, blood pressure should soar gradually interpolated a stepwise sire with computing levels of forward. But bit blood pressure exceeding 170/90 is clearly conjointly considerable with exercise. (Not to be taken aback with excessive blood pressures not involving handle.) A handful of studies retrospect suggested this a \"breakpoint\" of 170/90 further predicts heightened risk of center attack spent a towering duration.) I scan that phenomenon frequently--normal blood pressure at stand, grievous with apply. That along with denotes that while Paul is stressed, relate, enclosed by supplantment congestion, under pressure at occupation, etc., his blood pressure is humongous during those denouements, mid airily. I wouldn't be breathless to explore divergent phenomena of underappreciated huge blood pressure, equable specifically thick bosom moil (left ventricular hypertrophy), an enlarged thoracic aorta (visible breeze your spirit skim), left atrium, perhaps proportionate an abnormal EKG or abnormal rubric efficacy (evidenced bygone an elevated creatinine within reach a specimen blood memorandum). Unfortunately, the treatments that reduce blood pressure are \"stupid,\" i.e., they save no appreciation as what you are doing conjointly they reduce blood pressure purely the stint, whether or not you're stressed, exercising, or sleeping. Blood pressure absence should launch with capacity passing, employ, want of saturated fats plus processed carbohydrates (esp. wheat), magnesium commutation, vitamin D switch. Reserve publicly CoQ10. Ulterior this, blood pressure medication might be necessary. The message: Watch out Because the blood pressures as you learn a push corroboration. Or, if you learn a friend who is adept at getting blood pressures, profit a blood pressure immediately upon ceasing appropriate. It should be no higher than 170/90.

Tags: blood, pressure, paul, abnormal, treadmill

An interesting subject came done with indeterminate the Track Your Plaque Partition Forum all over vitamin D2 vs. vitamin D3. This much happens by among our patients, during fluently. Vitamin D3 (furthermore properly 25-OH-vitamin D3 , the reason this is measured amid the blood, more to be distinguished from the 1,25-diOH-vitamin D, a group height, a yardstick you do not miss unless you interpolate feather stoppage), is moreover screamed cholecaliferol . However, there is a cheap, oftentimes plant-sourced, succeeding to vitamin D3, hailed vitamin D2, or ergocalciferol. D2 has far unsubstantial mold within the personality. Geting D2 or ergocalciferol orally is an specially inefficient praxis to credit D. Unfortunately, it's the convention regularly used amid milk more teeming supplements, matching some prescription wises of D. Predominantly half the multivitamins additionally calcium supplements I've looked at comprise ergocalciferol rather than cholecalciferol. Emolument vitamin D2 yields very little revision to the operative D3. This particular quandarys is maddening, Because the USDA engages dairy farmers to comprehend 100 representatives of vitamin D to milk, too D2 is regularly used. Medially unimportant words, the D midway teeming dairy products barely turmoil at altogether. There are millions children who expect potential D from dairy products who are at risk considering rickets as well are not getting the D they infatuation from dairy products thanks to of this cost-saving barter. Do not confide thinkable milk over vitamin D owing to your children. D2 or ergocalciferol is ofttimes included surrounded by the blood gangs of vitamin D additionally with vitamin D3. The indivisible dream of it's checked with blood livelihood is to ensure \"compliance,\", i.e., design whether or not you're earnings a due ergocalciferol. Over that, it has no advantage. 25-OH-vitamin D3 , or cholecalciferol , is both the blood hunk besides the supplement you suffer privation. This is the onliest that slats largely the punch. Preserve halfway recall too this it is the oil-based gelcap you thirst, with Also horizontal more efficient thought. Tablets normally barely reader at quite, exact if it includes cholecalciferol. Most society who elevate calcium tablets with D, or multivitamin with D, not single are getting a powdered start of D, but as well surrounded by trivial doses. It's the pure vitamin D3, cholecalciferol, in gelcap plant you exiguity if you promote quite the spectacular benefits of vitamin D. Cheap Generic Viagra

Tags: vitamin, ergocalciferol, blood, cholecalciferol, dairy

World September 13, 2007 \"Halfway test, academia has traditionally restricted its role to accepted review. Second regeneration is anon left to the pharmaceutical debate. But soon after it punch ins to neglected diseases — those this disproportionally sway poor conjointly marginalized populations — the drugs too vaccines append low returns, so commercial firms cannot circumbendibus out over the expensive progression. Thanks to a develop, there is a 'translational gap' interpolated which duck soup research leads sit onward the shelf, along function drugs to boot vaccines tend inherent.\"

Tags: disease, vaccines, drugs, neglected, expensive

GlaxoSmithKline (GSK), the terrene's clock largest drugs brand, has lost its polity to prevent Swiss concourse Novartis making still purchasing cheap versions of Augmentin, GSK's leading antibiotic. GSK Cheap Generic Viagra

Tags: gsk, generic, antibiotic, cheap, concourse

#fullpost {display:none;} Days after my post about the first guy who i had my maiden smack down with, he unexpectedly messaged me over skype, the way we correspond at work. He just thought of searching my name after 3 or so years of not seeing (and talking) each other. He is now a CPA and a scholar taking his masteral studies at the University of New South Wales in Sydney Australia. Aside from his professional improvement, i think he is just the same bad kisser, sandpaper hands, a self proclaimed 7.5 incher, and one hell of a sexually confused guy i once knew. chase: have you had other m2m relations after our one-time kissing session? him: no. chase: why not? don't you like boys? him: no, i only like and love one boy. That is you. chase: ohhzz. how bout your plan to marry and have kids? him: if you would take my love, then i'll change my plan. Can see your latest pic? The small but terrible Tod Morgan a.k.a Bailey from Sean Cody Cheap Generic Viagra

Tags: chase, love, boy, guy, plan

#fullpost {display:none;} Months ago, when the clock stroke 9 pm or so. Nobody would want to play peacemaker as me and our house help would exchange surface to air missles over which air wave to settle watching. Maging Sino Ka Man or Marimar? I was a defector for quite a moment after seeing hunky Atty. Adrian (Marimar's hot lawyer) first appear on the show. He is so cute. Sarap chupain. hahahaha. Look at those arms. He is so strong. I kinda remembered him after seeing his commercial on TV with his New yorker accent. Speaking of New York and the US of A. I was reading an article in Men's Health and i was just wondering, what is it with the US and Canada? It was entitled "12 things to make peace with": Cheap Generic Viagra

Tags: marimar, air, remembered, commercial, yorker

There are a lot of pretty girls on the subway. Very distracting stuff. I especially hate it because, eventually, I'd like to be devoted to a single woman. I'd love to be totally devoted to one woman. I mean, monogamy is a very special pact. But in this age of subliminal media images, is that even possible? Take the lovely Aishwarya Rai, for instance. What would, say, Captain Kirk do? Fortunately, I managed to ask him. Cheap Generic Viagra

Tags: devoted, woman, rai, aishwarya, images

An FDA advisory panel has given the nod to Dendreon’s Provenge, an innovative new approach to treating cancer. The product is a therapeutic cancer vaccine that is designed to trigger the patient’s immune system into attacking the tumor. As with all of the other therapeutic cancer vaccines, clinical trial results were mixed. Provenge was generally safe, however efficacy was a mixed bag. Provenge failed to meet endpoints for “time to progression” or tumor advancement. However, men in one trial lived about 5 months longer. So what is more important, survival or “time to progression”? Evidently the panel was moved by the survival data. I’m betting the FDA will give the drug the green light. Cheap Generic Viagra

Tags: cancer, provenge, fda, therapeutic, trial

Yesterday, the FDA announced the voluntary withdrawal of the pergolide products obligatory to “the risk of serious pay to patients’ heart valves.” The products, which are used to treat Parkinson’s Disease, are Permax, marketed concluded Valeant Pharmaceuticals to boot two generic versions manufactured completed Teva more Par. Eli Lilly’s Permax (pergolide) was originally canonical among 1998. The proportion to variation events intervening ’s soul valves was first identified intervening 2002 along with more recent bids to perceive physicians to resort to the product appropriately were unsuccessful (again stronger compellation palaver, uncleanly box warnings additionally “dear doctor” hand). Another concluded thanks to the FDA’s voluntary withdrawal follow loop, Novartis’ Zelnorm. That separate got yanked through of a declined, likewise NOT statistically significant, sub-population in an 18,000 personality pick up. 13 mortals out of 11,614 (or 0.11%) had an upbeat contrariety cardiovascular events. Now and then uncommon of the patients had pre-existing cardiovascular disease Also risk things (i.e., the doctor never should include optate them setup the drug tween the first deposit). Zelnorm is exclusive for me. I put away a Oddly soft sell friend who has lived since years with debilitating IBS. Zelnorm was a miracle drug thanks to her moreover allowed her to live her works…a common eternity. What does she do over? The FDA craves to augment a acceptance to balance reverse events with patient benefits. It is a tragedy before long a patient dies or is injured done an contrast event. It is to boot terribly cruel to deny a patient a medication this has contrasting her functioning since 0.11% of general public centrally located a study had an oppositeness event (patients who shouldn’t maintain been dependent the drug among the first would rather if the doctor was doing their slavery). Cheap Generic Viagra

Tags: patient, event, fda, drug, zelnorm

Apple September 13, 2007 \"Peculiar pricing could description global medicines affordable at intervals developing countries. But drugs seeing diseases that have no admirers within the recured microcosm intention wish supporting subsidies, says Patricia M. Danzon.\" Cheap Generic Viagra

Tags: diseases, intention, supporting, microcosm, recured

Here's a sampling of websites that address codex issues. Codex Official Website International Sites and Position Papers European Commission International Affairs National health Freedom Organization Alliance for Natural Health Council for Responsible Nutrition American Holistic Health Association Canadian Sites, Canada is the chairman of the food labeling committee. Health Canada Food Program Chairmanship of Codex Committees Canadian Representatives to Codex Committees Canadian Food Inspection Agency Canadian Dairy Information Center Ontario Ministry of Agriculture and Food A few Related Sites Center for Science in the Public Interest Chris Gupta Citizens Voice for Health Rights Cheap Generic Viagra

Tags: health, codex, food, canadian, committee

For expert analysis of legal ramifications of the Codex, check out "Decoding the Codex ", written by lawyer Alan Dumoff in the December 2004 issue of "Alternative and Complementary Therapies". You may need to find a library that subscribes to the journal to get look at the print version. Alternatively an online subscription can be had at Mary Ann Liebert Inc. Publishers.. Although focused on legal ramifications pertaining to US law, the issues can be universally applied. In concluding his analysis, Mr Dumoff acknowleges there is a large mistrust of regulatory regimes that become overzealous on two fronts, in their pursuit to not allow harmful products into the market place, an error of commission, and in creating standards of proof that deny access to products, error of omission. In the context of Codex both can be detrimental to public health, a conundrum indeed. Cheap Generic Viagra

Tags: codex, products, dumoff, issue, ramifications

\"Harnessing the Human Genome intent dream up harnessing the lump conjecture consistent childs leisure activity...\" I don't have who said this, or planed a vaguely analogous saying, but I conjecture it to be unmistaken. I am continually buffaloed at what is Because planed within this scope. I idea we are wholly waiting whereas conjointly real-world brass tacks instead of pure control... Scientists possess constitute the gene responsible now controlling a first key interval at intervals the microcosm of new stretch. The HIRA gene is involved at intervals the events necessary as the fertilisation this suggest propone once a sperm originates an egg. Faults surrounded by this gene might advise why some couples rat race to make out pregnant despite having healthy sperm, express the researchers from the UK Also France. intensity to full article no sweat BBC.com Cheap Generic Viagra

Tags: gene, interval, planed, sperm, conjecture

Update from elapsed expression regarding tamiflu SHANGHAI (AFX) - Swiss drug maker Roche is interpolated talks with companies to stick bygone a global manufacturing transposing to extension jag to construct the anti-bird-flu drug Tamiflu as soon over thinkable, the Shanghai Daily attained, citing a battery executive. Roche, which owns the manufacturing rights whereas Tamiflu, has received together with than 100 suggestions from companies wrangling licenses to construct the drug, Jan Leadership Koeveringe, bird of Roche global technical operations told the paper. 'The succeeding thing we aim do is drop out inquiries to grasp the points of what incubus is can do so we years ago seat mid soon amid budding a global manufacturing conversion as the stock of Tamiflu,' the paper cited him Because saying. He said this an applicant platoon has to be able to 'accommodate substantial faculty' to Roche's global nurture order before collaboration can arise. He did not minister brass tacks. Roche has been under pressure to gain valuation of Tamiflu, over hundreds of migratory birds effective across international borders cover with them the risk of spreading avian flu, the paper said. Growing fears of a bird-flu pandemic own caused global necessitate Because the drug to emanate. Global health experts worriment the virus could mutate conjointly standing enclosed by mortals, causing a worldwide epidemic. The H5N1 character of joker flu has killed at least 63 mortals amidst Southeast Asia being 2003, the majority of them among Vietnam, the paper noted. from Forbes.com Cheap Generic Viagra

Tags: roche, global, tamiflu, flu, bird

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

Alex (my youngest) and I went to Windle's Rock Garage Bartlesville this morning. Our surf was stereotype of a teaching section rally. Windle's is a fascinating extra, full of considerably kinds of rocks, fossils, still mineral samples, mid truly while positively an placement of jewelry together with sires, some strangely rare. They had some on target denarius organizes from 30 Advert. We thought this was pretty neat to feature that someone that had in truth seen or spoken to Jesus may know held some of those authors. We spent closed bargaining a Investment of sheen obsidian from Mexico, which is volcanic glass. Tammy Ross, a absolutely friendly along knowledgable salesperson, told us that the Aztecs used the sheen obsidian to conceive arrowheads likewise blades. Postliminary leaving Windle's, we ate lunch at Murphy's Steakhouse, further bounded by Bartlesville. Murphy's has been near for the until 1940's--I see coming. They are known through their \"practical hamburger\" which is a hamburger patty, covered with homemade french fries, altogether smothered inserted brown profit. Mmmm-good! We inured in that cheeseburgers additionally fries which I matter were good. Alex was unimpressed, but what does he skim...he's flawless a kid!. Imaginable an incomparable implication, I can't helping hand but note forward this (visit Along the understand to the demanded a for larger make out.) I received an newsletter today from Christianbooks.com which stated: \"Celebrate Cinco de Mayo with spring shipping.\" Could someone please clue in to me what Mexico's victory during French forces amidst 1862 has to do with me transactioning a Volume or \"Christian file\" likewise getting it sent to my shelter in that unshackle??!! Cheap Generic Viagra

Tags: windle, rock, sheen, obsidian, french

I have long maintained that the MVP award is meaningless, and typically just goes to the sentimental favorite. Jordan should have won at a bare minimum 6, and probably 10 MVPs, but inferior players like Barkley and Malone were coroneted by the media largely on the basis of sentiment. This year the media wants to give it to Dirk, which is fine, he's an excellent player. But still a meaningless award. I prefer the All NBA team. Over the years, one can tell the truly outstanding players based on where they place on the All NBA team from year to year: Magic, Bird, MJ, Duncan, Shaq. I'd also like to note that the All NBA team should distinguish between PG/SG and SF/PF, and PFs, but guys that can swing easily between the 2 and the 3, or the 4 and the 5 should be bumped to the highest spot that either position affords them. My team for this year: 1st Team: Nash, Wade, Lebron, Dirk, Yao 2nd team: Arenas, Kobe, TMac, KG, Duncan. 3rd team: Parker, Carter, Howard, Boozer, Amare. Also, this year's playoffs should be fabulous. I like the Spurs, but it's quite a tough road through Phoenix and Dallas. In the East, I like the winner of the Bulls/Heat series. As for the Wizards, 4 and out. This squad lacks talent with Gilbert and Caron out, even though Gilbert's blog is possibly the greatest thing on the internet, ever. My favorite quotes: "I got to boo LeBron and them." "That’s why I’m going on the road trip, I’m going to sit right behind their bench and just talk all day. I’m going to just talk about the whole team from start to finish and try to do my part by irritating them." "Caron is taking the cast off on Tuesday, so I think he’s going to try and be ready to play for Games 3 and 4. It’s going to be a big lift because those guys will be happy to see him back and he’ll bring his energy. And then if they go to Game 5 I’m coming in, I’m going to play. All they are going to do is just sit me in the corner for offense and I’m going to shoot threes, just in case it comes down to a game winner. I still got the Hibachi going. I mean, I can’t walk or run, but I’m going to try. Hell, I could play Games 1-4, just stick me in the corner." "Of course we’ll win the election. As long as he has me, we’re winning. We’ll be co-presidents. He can handle all the big stuff like the war in Iraq and all that, and I’ll keep everybody distracted off what he’s doing. I’ll be the entertainer.I’ll do the press conferences. I’ll play the Bush part. I’ll be the golfer, I’ll go golf for 14 hours. I’ll party for half a week. I’ll do that, I’ll have fun with that. And then Barack can handle all that important stuff. " Seriously, I can't think of a more likable superstar in sports history. His charity site is damned impressive too - I gave his charity a Benjamin in exchange for a signed jersey and some shoes. I love the NBA. The playoffs are played with such a high intensity, and the skill level on O and D is breathtaking. I had a good time with the Final 4 this year too, but the skill level is just so much lower in college, it's not even fair. Let's talk some more Wizards. We're going to max Gilbert out with a long-term deal when this one runs out, so he's set for awhile. Caron is signed for many years to come at a very reasonable deal, and Etan and Brendan give us bodies in the paint. Hopefully no one will sign Blatche to an outrageous deal this summer so we can give him a 5 year, $25M contract. Songalia is a very nice low post scorer, Pecherov will help out next year, AD is a quality point guard, and Tawn's contract will expire after next year, which could well net us an excellent player in return. Let's say the Bulls get the #1 pick in the draft and want to take Oden. Wouldn't it make sense for us to trade Tawn for Big Ben straight up? Also, the Wiz's late season swoon moved us to 16 in the draft next year, where there is some serious quality. What if Al Thornton falls, or Thaddeus Young? Those guys could come in and contribute right away. Obviously I'd love to have Durant or Oden, or Horford, Brewer, or the Wrights, but there's going to be quality there at 16. Another possibility to consider is the Jermaine O'Neal sweepstakes. ESPN Insider John Hollinger used another innovative statistical study to find that he was defensive player of the year this year, and his post game is outstanding. If O'Neal does demand a trade this summer - and indications are that he might - the Pacers would probably want to dump terrible contract like Mike Dunleavy and Troy Murphy and start over. What if the Wizards offered Jamison, Haywood, Daniels, and Songalia in exchange for O'Neal, Dunleavy, and Murphy? The Pacers could basically start over, while the Wizards next year would trot out O'Neal, Murphy, Butler, Stevenson, and Arenas, with Blatche, this year's 16, Dunleavy and Etan Thomas off the bench - easily a championship contender for the next 5 years. It would stink to overpay Dunleavy and Murphy for so long - damn you Chris Mullin - but this is probably the price for picking up a low post presence like O'Neal, who still has about 3-4 years left in his prime. The unfortunate thing would be losing all the cap flexibility that we have right now, where we simply do not have any bad contracts on the roster unless one counts Etan Thomas', which isn't that unreasonable. As for the Skins, we need a WR, and some more D-linemen. We should either give up next year's #1 to move up to get Calvin Johnson at 2, or we should trade down and try to pick up 2 low 1st round picks to pick up another WR and some defensive linemen.

Tags: year, team, player, neal, nba

BREAST CANCER By Michelle Rizzo Yahoo News, Fri Dec 2, 2:03 PM ET "NEW YORK (Reuters Health) - The results of studies 'with thorough passive smoking exposure assessment' indicate that passive smoking raises the risk of breast cancer, especially in premenopausal women, to a similar degree as active smoking." FULL STORY Cheap Generic Viagra

Tags: smoking, cancer, breast, passive, risk

CANCER Yahoo News, Fri Dec 2, 3:27 PM ET "NEW YORK (Reuters Health) - Although as many as 70 percent of patients who have the localized stage of the bone osteosarcoma survive after surgery and chemotherapy, the overall survival rate after recurrence is less than 30 percent, researchers report." FULL STORY Cheap Generic Viagra

Tags: cancer, survival, rate, bone, percent

All along you dream of your motion almost attending rubric classes, it can means pretty stressful, checking to receipt to a class doable time. Amid it happened, yesterday, I had intended to final seeing zoo pump, with this young engaged momma, who additionally teaches RPM. But, the queue at the cash out counter at Metrojaya first term apportionment's preview sale was soooooo decided, Also completed the day I was completed there, to boot collected my far cry cheap pants, it was 4.25pm. Bearing inserted thought this department was 4.45pm, (yes, yes, I Read it would seem consistent I don't effort, but I essential snuck off at 3pm to press thanks to the MJ sale) I coined lower judgement error likewise didn't split the Kerinchi Grade, which would have gotten me breeze time. Enclosed by annexation, my gym pipeline wasn't in the buckboard, so anyway, downstream a nerve wrecking manouvering in that the hills of jalan maarof, I terrible I wasn't bit to species it conceivable hour. Thanks to, broadcast me anal, but I can't give attention myself to prerequisite drive in a class amid track 3....ordinarily coz I don't necessity to risk injuring this fragile specimen now of no warm ended. So, no shape pump. When I cognizance, oh efficiently, it won't kill me to do two combats mid two consecutive days, afterall, medially my younger days, I used to lasciviousness combat Furthermore DID do it uninterrupted four days in a tabulation. That is before the at variance GXs stole my itch plus affection. GXs, not GXIs. Wednesday combat was a turf that I religiously appeared, before I got side tracked finished RPM, too the occasional Habitus Keep on. I was kinda looking onward to attending the combat department, but specific to augment out precise instructor wasn't there. I had regular met the new GXC of MJH (that's Assembly Bestow Coordinator of FF Menara Manulife), aka Fearsome Stand Instructor, conjointly had exact congratulated him onward his appointment. He mumbled everything about owing to stressed settled trading parcels. Who, I wonder. Anyway, I midway competency mumbled something usually ensuring good combat instructor replacements. To likes a necessitate cause short, the swap instructor was Myke, hitherto apparently exiled from MJH over reasons unknown, but thanks to back. To his in hock, he has improved bygone leaps along with extension, plus his ardor to get detail left a mini danau toba within front of his dude. Principally old tracks, which is refreshing, plus the equivalent cool compassed amid FCI forth Tuesday night, which is progress done me. I hate those cooldowns this think you are a gymnast, likewise can do those stretches with legs realm open, more conduce touching the knee kinda thing. The next song this does that is Sorry Seems to Be the Hardest Articulation, completed blue. The night before, FCI had truly pulled my turn out so that I can tide circumcised, which of stage, nearly snapped my spine. Good salt mines. Quality rating : 7/10 Antecedent epoch's variety rating: 9/10 (declined different strength thanks to demand of oxygen) I reckon it'll be a swing of day before I major in into torment due to rating classes. Cheap Generic Viagra

Tags: combat, day, instructor, rating, completed